Efficacy and safety of systemic treatments for patients with recurrent/metastatic head and neck squamous cell carcinoma: A systematic review and network meta-analysis-Reference-Cited by-同舟云学术

Efficacy and safety of systemic treatments for patients with recurrent/metastatic head and neck squamous cell carcinoma: A systematic review and network meta-analysis

Published:2021-11 Issue: Volume:173 Page:105866
ISSN:1043-6618
Container-title:Pharmacological Research
language:en
Short-container-title:Pharmacological Research

Author:

Wang Huanhuan,Zhao Qin^ORCID,Zhang Yangyu,Wei Jinlong,Wang Bin,Zheng Zhuangzhuang,Liu Shiyu,Liu Zijing,Meng Lingbin,Xin Ying,Jiang Xin^ORCID

Publisher

Elsevier BV

Subject

Pharmacology

Reference60 articles.

1. Global cancer statistics 2018: GlOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J. Clin.,2018

2. Head and neck cancer;Argiris;Lancet,2008

3. State-of-the-art management of locally advanced head and neck cancer;Seiwert;Br. J. Cancer,2005

4. Locoregionally recurrent head and neck squamous cell carcinoma: incidence, survival, prognostic factors, and treatment outcomes;Chang;Oncotarget,2017

5. Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis;Bourhis;Lancet,2006

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative safety of immune checkpoint inhibitors in recurrent or metastatic head and neck squamous cell carcinoma: a systematic review and network meta-analysis;European Archives of Oto-Rhino-Laryngology;2024-02-15

2. Differential Expression of MicroRNA MiR-145 and MiR-155 Downstream Targets in Oral Cancers Exhibiting Limited Chemotherapy Resistance;International Journal of Molecular Sciences;2024-02-10

3. An open, multicenter, exploratory study of apatinib mesylate maintenance therapy for recurrent/metastatic head and neck squamous cell carcinoma (ChiCTR1800019375);Head & Neck;2024-01-14

4. Integrated multi‐omics analysis reveals unique signatures of paclitaxel‐loaded poly(lactide‐co‐glycolide) nanoparticles treatment of head and neck cancer cells;PROTEOMICS;2023-05-06

5. TRIM21 Expression as a Prognostic Biomarker for Progression-Free Survival in HNSCC;International Journal of Molecular Sciences;2023-03-07